E-Mail
Many genetic mutations have been found to be associated with a person's risk of developing Parkinson's disease. Yet for most of these variants, the mechanism through which they act remains unclear.
Now a new study in
Nature led by a team from the University of Pennsylvania has revealed how two different variations--one that increases disease risk and leads to more severe disease in people who develop Parkinson's and another that reduces risk--manifest in the body.
The work, led by Dejian Ren, a professor in the School of Arts & Sciences' Department of Biology, showed that the variation that raises disease risk, which about 17% of people possess, causes a reduction in function of an ion channel in cellular organelles called lysosomes, also known as cells' waste removal and recycling centers. Meanwhile, a different variation that reduces Parkinson's disease risk by about 20% and is present in 7% of the general population enhances the activity of the same ion channel.